v3.25.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues      
Product revenue, net $ 457,182 $ 397,614 $ 266,719
Collaboration revenue 2,974 1,374 0
Total revenues 460,156 398,988 266,719
Expenses      
Cost of product revenue (190,520) (147,118) (95,816)
Cost of collaboration revenue (561) (742) 0
Research and development (220,904) (234,504) (265,868)
Selling, general, and administrative (277,605) (298,741) (281,608)
Gain on sale of intellectual property 0 0 10,000
Loss from operations (229,434) (282,117) (366,573)
Interest income 33,048 37,105 39,797
Interest expenses (5,209) (2,254) 0
Foreign currency gains (losses) 19,591 (15,137) (14,850)
Other income, net 3,540 5,300 7,006
Loss before income tax (178,464) (257,103) (334,620)
Income tax benefit 2,927 0 0
Net loss $ (175,537) $ (257,103) $ (334,620)
Loss per share — basic (in dollars per share) $ (0.16) $ (0.26) $ (0.35)
Loss per share — diluted (in dollars per share) $ (0.16) $ (0.26) $ (0.35)
Weighted-average shares used in calculating net loss per ordinary share — basic (in shares) 1,095,311,090 989,477,730 966,394,130
Weighted-average shares used in calculating net loss per ordinary share —diluted (in shares) 1,095,311,090 989,477,730 966,394,130